Peter Selby MBBS, CCFP, FCFP, MHSc, dipABAM, DFASAM
Professor
DFCM
Dr. Peter Selby
Contact Info
Location
Centre for Addiction and Mental Health
Nicotine Dependence Service
1025 Queen Street West, 5th Floor
Toronto, ON, M6J 1H4
Accepting
Graduate Students
Postdoctoral Fellows
Research Interests
Addiction Medicine, Health Promotion, Knowledge Translation, Mental Health, Public Health, Experimental, Electronic Medical Records, Disadvantaged Populations, Mixed Methods, Survey Methods, Quantitative Data Analysis, Qualitative Data Analysis, Cancer Care, Education Research, Chronic Diseases, Quality Improvement, Social Determinants, Tobacco Dependence, Opioids

Clinician Scientist in the Addictions Division and Campbell Family Mental Health Research Institute, as well as a Senior Medical Consultant, at the Centre for Addition and Mental Health (CAMH), Toronto, Ontario, Canada.

Professor, Department of Family and Community Medicine, Dalla Lana School of Public Health, University of Toronto, Ontario, Canada.

Clinician Scientist, Addictions, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Research/Teaching

Research Synopsis

Dr. Peter Selby is a Clinician Scientist in the Addictions Division and Campbell Family Mental Health Research Institute, as well as a Senior Medical Consultant, at the Centre for Addition and Mental Health (CAMH). He is a Professor in the Departments of Family and Community Medicine, Psychiatry, and the Dalla Lana School of Public Health at the University of Toronto. He is also a Clinician Scientist in the Department of Family and Community Medicine.

Dr. Selby's research focus is on innovative methods to understand and treat addictive behaviours and their comorbidities. His work has a strong focus on pragmatic implementation trials using novel methods, with particular emphasis on the use of technological innovation to increase the reach and effectiveness of interventions.

Grants

Dr. Selby has received grant funding totaling over 85 million dollars from CIHR, NIH, and Ministry of Health.

2019 Oct – 2022 Sept Co-Investigator. Understanding the impact of smoking cessation treatment on health and healthcare service use among smokers in Ontario. Canadian Institutes of Health Research (CIHR). Project Grant – Spring 2019. PI: Baliunas D. Collaborator(s): De Oliveira C, Kurdyak P, Rosella L, Selby P, Sutradhar R, Zawertailo L. 286,876 CAD

2019 Jul – 2020 Mar Co-Principal Investigator. Low Risk Nicotine Use Guidelines. Health Canada Substance Use and Addictions Program. PI: Selby P, Dragonetti R, Minian N, Zawertailo L, Salach L, Dobbins M. 371,431 CAD

2018 Apr. – 2021 Apr. A Healthy People Initiative: A Randomized Controlled Trial Building the Socio-Economic Capital of Low Income Population At-Risk for HIV and Hepatitis C (HPI Pilot Trial). Canadian Institutes of Health Research (CIHR). Operating Grant: HIV/AIDS Commuity-Based Research (2017 – 2018). PI: Pakhale S, McKay E. Collaborator(s): Selby P, Willis V, Thavorn K, Ramsey T. 450,000 CAD.

2018 Jan. – 2021 Dec. A community-based participatory action pragmatic randomized controlled trial using electronic-cigarette for tobacco dependence in the low income population with a holistic approach. Canadian Institutes of Health Research (CIHR). Project Grant – Fall 2017. PI: Pakhale S, McKay E. Collaborator(s): Eisenberg MJ, Willis V, Barker K, Selby P, Perrin P, Thavorn K, Kretschmer L, Bignell T. 1,985,175 CAD.

2018 Apr. – 2020 Mar. De-implementation of high-risk opioid prescribing and use. Ontario Ministry of Health and Long-Term Care. PI: Selby P. 3,398,500 CAD.

2017 Nov. – 2019 Oct. Implementing lung cancer screening for those living with low income. Canadian Cancer Society Research Institute (CCSRI). Knowledge to Action Grant – 2017. Co-PI: Lofters A, Liu G. Collaborator(s): O’Brien MA, Chang B, Crosskill A, Eng L, Giuliani M, Hwang S, Kim F, Mowat D, Paszat L, Selby P, Vahabi M. 99,950 CAD.

2017 Oct. – 2019 Sept. My youth TECC study: MPA youth technology-enabled care collaboration study. Medical Psychiatry Alliance. PI: Selby P. Collaborator(s): Dettmer E, Foussias G, Grewal S, Hahn M, Kohut S, Lachance L, Melamed O, Mulsant B, Taylor V, Voineskos A, Zenlea I. 813,362 CAD.

2017 Jun. – 2022 May. Cannabis and brain maturation: A population-based study. Canadian Institutes of Health Research (CIHR). Project Grant – Fall 2016. PI: Paus T. Collaborator(s): Abrahamowicz M, Pausova Z, Pike B, Richer L, Seguin J, Selby P. 1,276,020 CAD.

2017 Jun. - 2019 May. A cluster randomized trial of tailored vs generic knowledge brokering to integrate mood management into smoking cessation interventions in primary care settings in Ontario, Canada. Canadian Institutes of Health Research (CIHR). Knowledge to Action. Co-PI: Selby P, Heydon A. Collaborator(s): Minian N, Ravindran A, Zawertailo L, Baliunas D. 200,000 CAD.

2017 Apr. – 2020 Mar. E-cigarettes for smoking cessation or harm reduction: Real-world comparative effectiveness to other cessation aids and tobacco co-use. Ontario Ministry of Health and Long-Term Care. Health Services Research Fund: 2016 Calls for Targeted Research. Co-PI: Selby P, Zawertailo L. Collaborator(s): Stanbrook M, Tilson M. 578,052 CAD.

2017 Apr. – 2018 Mar. A community-based participatory action pragmatic randomized controlled trial using electronic-cigarette for tobacco dependence in the inner city population with a holistic approach. Canadian Institutes of Health Research (CIHR). Project Grant – Fall 2017. PI: Pakhale S, Boyd R. Collaborator(s): Selby P, Eisenberg M, Thavorn K. 100,000 CAD.

2017 Apr. – 2018 Mar. Addiction training module for families. Centre for Addiction and Mental Health Foundation. PI: Selby P. 21,250 CAD.

2017 Apr. - 2018 Mar. Training Enhancement in Applied Cessation Counselling and Health (TEACH): A program to enhance capacity for delivery of smoking cessation interventions in Ontario. Ontario Ministry of Health and Long-Term Care. PI: Selby P. Collaborator(s): Dragonetti R. 1,620,000 CAD.

2017 Apr. - 2018 Mar. The STOP (Smoking Treatment for Ontario Patients) Study: The effectiveness of nicotine replacement therapy in Ontario smokers. Ontario Ministry of Health and Long-Term Care. PI: Selby P. Collaborator(s): Zawertailo L. 7,081,500 CAD.

2017 Mar. – 2019 Feb. Tobacco addiction treatment implementation and scale up in dental care settings: A mixed methods study. Pfizer Inc. (USA). Global Research Awards for Nicotine Dependence (GRAND). PI: Selby P. Collaborator(s): Saunders D, Ebnahmady A, Zawertailo L, Baliunas D, deRuiter W, Le Foll B, Minian N. 184,762 USD.

2016 Dec. – 2018 Jun. Addiction and suicide research. Centre for Addiction and Mental Health Foundation. PI: Selby P. 90,102 CAD.

2016 Nov. – 2022 Mar. Picking up the PACE (Promoting and Accelerating Change through Empowerment): Expanding tobacco cessation training curriculum to promote integrated chronic disease prevention. Public Health Agency of Canada (PHAC) and Medical Psychiatry Alliance. Co-PI: Selby P, Taylor V. Collaborator(s): Zawertailo L, Minian N, deRuiter W, Melamed O, Ebnahmady E. 1,046,904 CAD.

2016 Nov. - 2019 Oct. Long-term effectiveness of mailed nicotine replacement therapy: A five-year follow-up. Canadian Cancer Society Research Institute (CCSRI). Prevention Research Grant. PI: Cunningham JA. Collaborator(s): Leatherdale S, Selby P, Zawertailo L, Tyndale R. 442,254 CAD.

2016 Nov. – 2017 Jul. Improving tobacco dependence treatment for Ontario’s Inuit community through a community-based participatory approach. Bhasin Consulting Fund Inc. Fund for Inclusion in Mental Health. Co-PI: Selby P, Barker M. Collaborator(s): Lund C, Dragonetti R. 8,500 CAD.

2016 Apr. - 2017 Mar. Training Enhancement in Applied Cessation Counselling and Health (TEACH): A program to enhance capacity for delivery of smoking cessation interventions in Ontario. Ontario Ministry of Health and Long-Term Care. PI: Selby P. Collaborator(s): Dragonetti R. 1,620,000 CAD.

2016 Apr. - 2017 Mar. The STOP (Smoking Treatment for Ontario Patients) Study: The effectiveness of nicotine replacement therapy in Ontario smokers. Ontario Ministry of Health and Long-Term Care. PI: Selby P. Collaborator(s): Zawertailo L. 7,114,500 CAD.

2016 Oct. - 2018 Sep. Using non-invasive brain stimulation (tDCS) to improve the effectiveness of varenicline for treating tobacco dependence: A randomized controlled trial. Pfizer Inc. (USA). Global Research Awards for Nicotine Dependence. PI: Zawertailo L. Collaborator(s): Selby P, Zack M, Rajji T. 191,566 USD.

2016 Aug. - 2019 Jul. Building effective teams: The implementation of a web-based clinical collaboration system. Canadian Cancer Society Research Institute (CCSRI). Innovation to Impact Grant. PI: Husain A. Collaborator(s): Barwick M, Stinson J, Cafazzo J, Jamieson T, Cohen E, Rapoport A, Goldman R, Bezak A, Krzyzanowska M, Selby P, Loganathan M, Bhatia S. 450,000 CAD.

2016 Jun. - 2018 May. A cluster randomized trial of tailored vs generic knowledge brokering to integrate mood management into smoking cessation interventions in primary care settings in Ontario, Canada. Canadian Institutes of Health Research (CIHR). Knowledge to Action. Collaborator(s): Minian N, Ravindran A, Zawertailo L, Baliunas D. 200,000 CAD.

2015 Nov. - 2019 Oct. Advancing cancer prevention in deprived neighbourhoods. Canadian Cancer Society and Canadian Institutes of Health Research - Institute of Cancer Research. Prevention Research Grant. PI: Paszat L. Collaborator(s): Lofters A, Pinto A, O’Brien MA, Sutradhar R, Selby P, Grunfeld E, Manca D, Lansdorp-Vogelaar I, Sullivan F, Glazier R, Donnelly P, Rabeneck L, Baxter N, Tinmouth J, Kyle R, Petrusiak MA, Nesbitt J, Wall B, Pellizzari R, Gardner C, Simon L. 597,042 CAD.

2015 Apr. - 2017 Mar. Opioid prescribing patterns for acute pain. Canadian Centre On Substance Abuse. First Do No Harm. Collaborator(s): O’Grady T, Porath-Waller A, Robeson P, Gomes T, Sproule B, Wallingford S, Patterson Z. 13,000 CAD.

2015 Apr. - 2016 Mar. Training Enhancement in Applied Cessation Counselling and Health (TEACH): A program to enhance capacity for delivery of smoking cessation interventions in Ontario. Ontario Ministry of Health and Long-Term Care. Collaborator(s): Dragonetti, R. 1,620,000 CAD.

2015 Apr. - 2016 Mar. The STOP (Smoking Treatment for Ontario Patients) Study: The effectiveness of nicotine replacement therapy in Ontario smokers. Ontario Ministry of Healthand Long-Term Care. Collaborator(s): Zawertailo, L. 1,281,000 CAD.

2015 Feb. - 2020 Jan. Personalized dosing of nicotine replacement for smoking cessation: An effectiveness randomized placebo-controlled trial. Canadian Cancer Society. Impact Grant. PI: Selby P, Zawertailo L. Collaborator(s): Hendershot C, Tyndale R, Le Foll B, Samokhvalov A, Thorpe K, Pipe A, Reid R. 1,239,026 CAD.

2015 Feb. - 2017 Jan. Personalized patient alerts and care pathways to prompt prevention interventions for combined alcohol and tobacco users in primary care. Canadian Cancer Society. Innovation Grant. Collaborator(s): Hendershot C, Minian N, Zawertailo L, Penner J, Giesbrecht N, Samokhvalov A, Rehm J, Baliunas D, Cunningham J, Le Foll B, Ivanonva A, Rahman F. 199,900 CAD.

2014 Jul. - 2015 Jun. Pregnets: online pre and post-natal smoking support for women and healthcare providers. Canadian Institutes of Health Research (CIHR). Planning and Dissemination Grant–Institute Community Support. Collaborator(s): Lessels C, Minian N, Penner J. 10,000 CAD.

2014 Apr. - 2016 Mar. RE-CIG: Research on e-cigarettes. Ontario Ministry of Health and Long-Term Care. Health Services Research Fund. PI: Zawertailo L, Schwartz R. Collaborator(s): Selby P, Ferrence R, O’Connor S. 499,925 CAD.

Publications and Awards

View PubMed search of this faculty member's recent publications.

Recent Publications

Espinet S, Corrin T, Baliunas D, Quilty L, Zawertailo L, Rizvi SJ, deRuiter W, Bonato S, De Luca V, Kennedy S, Selby P. Predisposing and protective factors influencing suicide ideation, attempt, and death in patients accessing substance use treatment: A systematic review and meta-analysis protocol. Systematic Reviews. 2019 May 15;8(1):115. Senior Responsible Author.

Liu SY, Lu L, Pringle D, Mahler M, Niu C, Charow R, Tiessen K, Lam C, Halytskyy O, Naik H, Hon H, Irwin M, Pat V, Gonos C, Chan CWT, Villeneuve J, Shani RM, Chaudhry M, Brown MC, Selby P, Howell D, Xu W, Alibhai SMH, Jones JM, Liu G, Eng L. Impact of immigration status on health behaviors and perceptions in cancer survivors. Cancer Medicine. 2019 May;8(5):2623-2635. Coauthor or Collaborator.

Giuliani ME, Liu G, Xu W, Dirlea M, Selby P, Papadakos J, Abdelmutti N, Yang D, Eng L, Goldstein DP, Jones JM. Implementation of a novel electronic patient-directed smoking cessation platform for cancer patients: Interrupted time series analysis. Journal of Medical Internet Research. 2019 Apr 9;21(4):e11735. doi: 10.2196/11735. Coauthor or Collaborator.

Dowlati Y, de Jesus DR, Selby P, Fan I, Meyer JH. Depressed mood induction in early cigarette withdrawal is unaffected by acute monoamine precursor supplementation. Neuropsychiatric Disease and Treatment. 2019 Jan 23;15:311-321. Coauthor or Collaborator.

Hersi M, Traversy G, Thombs BD, Beck A, Skidmore B, Groulx S, Lang E, Reynolds DL, Wilson B, Bernstein SL, Selby P, Johnson-Obaseki S, Manuel D, Pakhale S, Presseau J, Courage S, Hutton B, Shea BJ, Welch V, Morrow M, Little J, Stevens A. Effectiveness of stop smoking interventions among adults: Protocol for an overview of systematic reviews and an updated systematic review. Systematic Reviews. 2019 Jan 19;8(1):28. Coauthor or Collaborator.

Eng L, Pringle D, Su J, Espin-Garcia O, Niu C, Mahler M, Halytskyy O, Charow R, Lam C, Shani RM, Villeneuve J, Tiessen K, Dobriyal A, Zarrin A, Vennettilli A, Brown MC, Alibhai SMH, Howell D, Jones JM, Selby P, Xu W, Liu G. Patterns, perceptions and their association with changes in alcohol consumption in cancer survivors. European Journal of Cancer Care. 2019 Jan;28(1):e12933. Coauthor or Collaborator.

Eng L, Pringle D, Su J, Shen X, Mahler M, Niu C, Charow R, Tiessen K, Lam C, Halytskyy O, Naik H, Hon H, Irwin M, Pat V, Gonos C, Chan C, Villeneuve J, Harland L, Shani RM, Brown MC, Selby P, Howell D, Xu W, Liu G, Alibhai SMH, Jones JM. Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivors. Support Care Cancer. 2018 Nov;26(11):3755-3763. Coauthor or Collaborator.

Zawertailo L, Mansouradeghi T, Zhang H, Hussain S, Le Foll B, Selby P. Varenicline and bupropion for long-term smoking cessation (the MATCH Study): Protocol for a real-world, pragmatic, randomized controlled trial. Journal of Medical Internet Research, Research Protocols. 2018 Oct 18;7(10):e10826. Senior Responsible Author.

Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L’Abbé M, Lau DCW, Leiter LA, O’Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. Canadian Medical Association Journal. 2018 Oct 9;190(40):E1192-E1206. Coauthor or Collaborator.

Selby P, Voci S, Zawertailo L, Baliunas D, Dragonetti R, Hussain S. Public health impact of a novel smoking cessation outreach program in Ontario, Canada. BMC Public Health. 2018 Sep 14;18(1):1117. Principal Author.

Gershon AS, Campitelli MA, Hawken S, Sproule BA, Selby P. Reply to Goulden et al.: Risk of bias in study of varenicline and cardiovascular outcomes. American Journal of Respiratory and Critical Care Medicine. 2018 Sept 1;198(5):691-692. Coauthor or Collaborator.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Gregoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS, Hypertension Canada. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Canadian Journal of Cardiology. 2018 May;34(5):506-525. Coauthor or Collaborator.

Alton D, Eng L, Lu L, Song Y, Su J, Farzanfar D, Mohan R, Krys O, Mattina K, Harper C, Liu S, Yoannidis T, Milne R, Brown MC, Vennettilli A, Hope AJ, Howell D, Jones JM, Selby P, Xu W, Goldstein DP, Liu G, Giuliani ME. Perceptions of continued smoking and smoking cessation among patients with cancer. Journal of Oncology Practice. 2018 May;14(5):e269-e279. Coauthor or Collaborator.

Minian N, Noormohamed A, Baliunas D, Zawertailo L, Mulder C, Ravindran A, de Oliveira C, Selby P. Tailored versus generic knowledge brokering to integrate mood management into smoking cessation interventions in primary care settings: Protocol for a cluster randomized controlled trial. Journal of Medical Internet Research, Research Protocols. 2018 Apr 27;7(4):e111. Senior Responsible Author.

Cunningham JA, Kushnir V, Selby P, Tyndale RF, Zawertailo L, Leatherdale ST. Beyond quitting: Any additional impact of mailing free nicotine patches to current smokers? Nicotine & Tobacco Research. 2018 Apr 2;20(5);654-655. Coauthor or Collaborator.

Ye L, Goldie C, Sharma T, John S, Bamford M, Smith PM, Selby P, Schultz ASH. Tobacco-nicotine education and training for health-care professional students and practitioners: A systematic review. Nicotine & Tobacco Research. 2018 Apr 2;20(5):531-542. Coauthor or Collaborator.

Gershon AS, Campitelli MA, Hawken S, Victor C, Sproule BA, Kurdyak P, Selby P. Cardiovascular and neuropsychiatric events after varenicline use for smoking cessation. American Journal of Respiratory and Critical Care Medicine. 2018 Apr 1; 197(7):913-922. Coauthor or Collaborator.

Zawertailo L, Voci S, Selby P. The cigarette dependence scale and heaviness of smoking index as predictors of smoking cessation after 10 weeks of nicotine replacement therapy and at 6-month follow-up. Addictive Behaviors. 2018 Mar;78:223-227. Senior Responsible Author.

Bruneau J, Ahamad K, Goyer ME, Poulin G, Selby P, Fischer B, Wild TC, Wood E, CIHR Canadian Research Initiative in Substance Misuse. Management of opioid use disorders: A national clinical practice guideline. Canadian Medical Association Journal. 2018 Mar 5;190(9):E247-E257. Coauthor or Collaborator.

Minian N, deRuiter WK, Lingam M, Corrin T, Dragonetti R, Manson H, Taylor VH, Zawertailo L, Ebnahmady A, Melamed OC, Rodak T, Hahn M, Selby P. The effects of interventions targeting multiple health behaviors on smoking cessation outcomes: A rapid realist review protocol. Systematic Reviews. 2018 Mar 1;7(1):38. Senior Responsible Author.

Barker M, Lecce J, Ivanova A, Zawertailo L, Dragonetti R, Selby P. Interprofessional communities of practice in continuing medical education for promoting and sustaining practice change: A prospective cohort study. Journal of Continuing Education in the Health Profession. 2018 Spring;38(2):86-93. Senior Responsible Author.

Minian N, Noormohamed A, Zawertailo L, Baliunas D, Giesbrecht N, Le Foll B, Rehm J, Samokhvalov A, Selby PL. A method for co-creation of an evidence-based patient workbook to address alcohol use when quitting smoking in primary care: A case study. Research Involvement and Engagement. 2018 Feb 5;4:4 doi:10.1186/s40900-018-0086-2. Senior Responsible Author.

Trigo JM, Soliman A, Quilty LC, Fischer B, Rehm J, Selby P, Barnes AJ, Huestis MA, George TP, Streiner DL, Staios G, Le Foll B. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. PLoS One. 2018 Jan 31;13(1): e0190768. Coauthor or Collaborator.

Zawertailo, L, Dragonetti, R, Bondy, SJ, Victor, JC, Selby, P. Reach and effectiveness of mailed nicotine replacement therapy for smokers: 6-month outcomes in a naturalistic exploratory study. Tobacco Control. 2013 May;22(3):e4. Senior Responsible Author.

Selby P, Brosky G, Oh PI, Raymond V, Ranger S. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial. BMC Medical Research Methodology. 2012 Jul 23;12(101):1-13. Principal Author

Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, Selby P, Martin PR, Fischer G. Neonatal Abstinence Syndrome after methadone or buprenorphine exposure. New England Journal of Medicine. 2010 Dec 9;363(24):2320-2331. Coauthor or Collaborator.

Selby P, Voci S, Zawertailo L, George TP, Brands B. Individualized smoking cessation treatment in an outpatient setting: Predictors of outcome in a sample with psychiatric and addictions co-morbidity. Addictive Behaviours. 2010 Sep;35(9):811-817. Principal Author.

Bader P, McDonald P, Selby P. An algorithm for tailoring pharmacotherapy for smoking cessation: Results from a Delphi panel of international experts. Tobacco Control. 2009;18(1):34-42. Senior Responsible Author.

Honours and Awards

2019 Ivan Silver Innovation Award, Continuing Professional Development, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

2018 Continuing Education and Graduate Studies Instructor Award, Dept of Family & Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

2016 2016 LEADing Practice Award, Canada Health Infoway and Accreditation Canada, Toronto, Ontario, Canada. (Clinical Practice, Specialty: STOP Portal).

2014 Fellow, Training Institute for Dissemination and Implementation Research in Health (TIDIRH), Harvard School of Public Health, Boston, Massachusetts, United States. (Distinction).

2014 Clinician Scientist Investigator Award, Department of Family and Community Medicine, University of Toronto, Canada, Toronto, Ontario, Canada.

2012 Physician Achievement Award, OMA section on Addiction Medicine, Canada. (Distinction).

2011 President’s Shield Award, Addictions Ontario, Canada. (Distinction).

2007 Award of Excellence, Ontario College of Family Physicians, Canada. (Distinction).

2007 Outstanding Award, Nova Scotia’s South Shore Health Outstanding Quality Initiative Award, Canada. (Distinction).

2006 Fellow, American Society of Addiction Medicine (ASAM), Toronto, United States. (Distinction).

2006 Smoke-Free Champion Award, Ontario Public Health Association (OPHA), Canada. (Distinction).